Question: COMPANY Name: Oracle Corporation Ticker Symbol: ORCL
- Determine whether the company was a generator of cash or a user of cash for the 2013-2016 period, and whether it is expected to be a generator of cash or a user of cash for 2017 and 2019-2021. Include a table showing the company's cash flow per share, capital spending per share, and free cash flow for every year between (and including) 2013 and 2016. In the table, include the expected data for 2017 and 2019-2021. Be sure to comment on the relevant results and your findings in the executive summary. KEY: Refer to Value Line as needed
- Using the firm's balance sheet and income statement, create two source and use of funds statements for the 2014-2016 fiscal periods (two statements). Allocate the sources to the uses, and be certain to analyze in writing the results of your allocations. Organize your sources and uses allocations according to the uses. In other words, allocate a source or mixture of sources to each individual use, and do not split up any use of funds. Be sure to comment on the relevant results and your findings in the executive summary.
- Calculate the sustainable growth rate for the company, and compare it to the projected rate of growth given in Value Line. Be sure to comment on the relevant results and your findings in the executive summary.
- Research the company's outstanding long-term debt (even if it is maturing in less than a year), and provide a table showing the coupon rates, the exact dates of maturity, preferably whether the bonds are callable (and if so, when; refer to the listed call price if necessary), and why the bonds were issued (if possible and/or available). Do the same for any long-term notes outstanding. Include data on current yields if it is available. Include the yield to maturity or yield to worst as well whenever possible. Be sure to comment on the relevant results and your findings in the executive summary. KEY: Refer to S&P's NetAdvantage (see the Fixed Income/Securities Summary section) and the most recent 10-K.